DEGs identified in this pathway include IL1A, TNF, TGFA, and RANKL. RANKL (log2 fold change = 7.39) is a potent stimulator of NF-κB and its expression is associated with tumor migration and invasion in HCC (Song et al., 2014). The gene discussed is TGFA; the disease is hepatocellular carcinoma.